Oral Anticoagulant Monitoring by Laboratory or Near-Patient Testing: What a Clinician Should Be Aware Of

Seminars in Vascular Medicine

Volumn 3, Issue 3, 2003, Pages 243-254

  Tripodi, A ^b   Breukink Engbers, W G M ^c   Van den Besselaar, A M H P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c AntiStollingsCentrum Oost Nederland ^*  (Netherlands)

Author keywords

International Normalized Ratio; Near patient testing; Oral anticoagulation

Indexed keywords

ANTICOAGULANT AGENT; CITRATE SODIUM; HEPARIN; LUPUS ANTICOAGULANT;

ANTICOAGULATION; BLOOD SAMPLING; CALIBRATION; DRUG MONITORING; FREEZING; INSTRUMENTATION; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; MEASUREMENT; PROTHROMBIN TIME; QUALITY CONTROL; REVIEW; STANDARDIZATION; STORAGE; TEMPERATURE; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DRUG MONITORING; HEMATOLOGY; HUMANS; INTERNATIONAL NORMALIZED RATIO; LABORATORIES; PROTHROMBIN TIME; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; WARFARIN;

EID: 0142040248     PISSN: 15289648     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-44460     Document Type: Review

References (54)

1. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119:8S-21S
2. WHO Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to monitor oral anticoagulant therapy. World Health Organization Technical Report Series, 1999; No. 889
3. van den Besselaar AMHP, Aillaud MF, Denson KWE, et al. Influence of three types of automated coagulometers on the international sensitivity index (ISI) of rabbit, human and recombinant human tissue factor preparations. Thromb Haemost 1999;81:66-70
4. Poller L, van den Besselaar AMHP, Jespersen J, Tripodi A, Houghton D. The European Concerted Action on Anticoagulation (ECAA): field studies of coagulometers effects on the ISI of ECAA thromboplastins. Thromb Haemost 1998;80:615-623
5. Johnston M, Harrison L, Moffat K, Willan A, Hirsh J. Reliability of the international normalized ratio for monitoring the induction phase of warfarin: comparison with the prothrombin time ratio. J Lab Clin Med 1996;128:214-217
6. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, Weg JG. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119:176S-193S
7. van den Besselaar AMHP, Meeuwisse-Braun J. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing. Blood Coag Fibrinol 1993;4:635-638
8. Tripodi A. The risk of heparin-neutralizing substances. Am J Clin Pathol 1999;111:566
9. Della Valle P, Crippa L, Safa O, et al. Potential failure of the international normalized ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants. Ann Med Intern 1996;147:10-14
10. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-185
11. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring oral anticoagulation therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Haematol 1997;98:887-892
12. Robert A, Le Querrec A, Delahousse B, et al. Control of oral anticoagulation in patients with the antiphospholipid syndrome. Influence of the lupus anticoagulant on international normalized ratio. Thromb Haemost 1998;80:99-103
13. Tripodi A, Chantarangkul V, Clerici M, Negri B, Galli M, Mannucci PM. Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. Br J Haematol 2001;115:672-678
14. Rapaport SI, Le DT. Thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;333:665
15. Lassen JF, Brandslund I, Antonsen S. International Normalized Ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem 1995;41:444-447
16. Jacobs P. Concentration of citrate anticoagulant. Am J Clin Pathol 1973;60:941
17. Chantarangkul V, Tripodi A, Clerici M, Negri B, Mannucci PM. Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations. Thromb Haemost 1998;80:258-262
18. Lottin L, Woodhams BJ, Saureau MC, Robert A, Aillaud MF, Arnaud E, Martinoli JL. The clinical relevance of the citrate effect on International Normalized Ratio determinations depends on the reagent and instrument combination used. Blood Coagul Fibrinolysis 2001;12:399-404
19. van den Besselaar AMHP, Chantarangkul V, Tripodi A. A comparison of two sodium citrate concentrations in two evacuated blood collection systems for prothrombin time and ISI determination. Thromb Haemost 2000;84:664-667
20. van den Besselaar AMHP, van Dam W, Sturk A, Bertina RM. Prothrombin time ratio is reduced by magnesium contamination in evacuated blood collection tubes. Thromb Haemost 2001;85:647-650
21. Vadher BD, Lloyd M, Parker N, Patterson DLH. Effect of sample storage on the International Normalized Ratio. Br J Haematol 1997;97:936-937
22. Hernández AG, Martín de Segovia JM, Villanueva JR. Refrigerated stored specimens are not reliable for delayed INR determination. Br J Haematol 1997;98:781-782
23. Froom P, Abramova D, Bar-El M, Barak M. Reliability of delayed prothrombin time INR determinations in a central laboratory using off-site blood sampling. Clin Lab Haematol 2001;23:189-192
24. Baglin T, Luddington R. Reliability of delayed INR determination: implications for decentralized anticoagulant care with off-site blood sampling. Br J Haematol 1997;96:431-434
25. Brigden ML, Graydon C, McLeod B, Lesperance M. Prothrombin time determination. The lack of need for a discard tube and 24-hour stability. Am J Clin Pathol 1997;108:422-426
26. Ridyard J, Bhavnani M, Seal LH. Laboratory control of oral anticoagulant therapy: preservation of prothrombin time specimens using a polypropylene collection system. Clin Lab Haematol 1998;20:369-372
27. Leeming DR, Craig S, Stevenson KJ, Taberner DA. The determination of INR in stored whole blood. J Clin Pathol 1998;51:360-363
28. Woodhams B, Girardot O, Blanco MJ, Colesse G, Gourmelin Y. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis 2001;12:229-236
29. Poller L, Keown M, Shepherd SA, Shiach CR, Tabeart S. The effects of freeze drying and freeze drying additives on the prothrombin time and the international sensitivity index. J Clin Pathol 1999;52:744-748
30. van den Besselaar AMHP. Precision and accuracy of the International Normalized Ratio in oral anticoagulant control. Haemostasis 1996;26:248-265
31. Preston FE. Quality control and oral anticoagulation. Thromb Haemost 1995;74:515-520
32. van den Besselaar AMHP. Field study of lyophilised plasmas for local prothrombin time calibration in the Netherlands. J Clin Pathol 1997;50:371-374
33. Loeliger EA, van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemost 1985;53:148-154
34. Tomenson JA. A statistician's independent evaluation. In: van den Besselaar AMHP, Gralnick HR, Lewis SM, eds. Thromboplastin Calibration and Oral Anticoagulant Control. Boston, MA: Martinus Nijhoff; 1984:87-108
35. Attermann J. Monitoring oral anticoagulant therapy: measuring coagulant activity. Ph.D. thesis. Faculty of Health Sciences, University of Aarhus, 2000
36. Macik BG. Designing a point-of-care program for coagulation testing. Arch Pathol Lab Med 1995;119:929-938
37. Ruzicka K, Kapiotis S, Quehenberger P, et al. Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguChek Plus® in various clinical settings. Thromb Res 1997;87:431-440
38. Kitchen S, Preston FE. Monitoring oral anticoagulant treatment with the TAS near-patient test system: comparison with conventional thromboplastins. J Clin Pathol 1997;50:951-956
39. van den Besselaar AMHP, Breddin K, Lutze G, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coagul Fibrinolysis 1995;6:726-732
40. Andrew M, Ansell JL, Becker DM, et al. Point-of-care prothrombin time measurement for professional and patient self-testing use. Am J Clin Pathol 2001;115:288-296
41. Zweig SE, Meyer BG, Sharma S, et al. Membrane-based, dry-reagent prothrombin time tests. Biomed Instrum Technol 1996;30:245-256
42. Tripodi A, Arbini AA, Chantarangkul V, et al. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio? Thromb Haemost 1993;70:921-924
43. Tripodi A, Chantarangkul V, Mannucci PM. Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 2001;113:847-852
44. Poller L, Keown M, Chauhan N, et al. European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems. Br J Haematol 2002;116:844-850
45. Attermann J, Kynde K, Hasenkam JM. Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer. Thromb Res 1998;92:287-291
46. Taborski U, Müller-Berghaus G. State-of-the-art patient self-management for control of oral anticoagulation. Semin Thromb Hemost 1999;25:43-47
47. Havrda DE, Hawk TL, Marvin CM. Accuracy and precision of the CoaguChek S versus laboratory INRs in a clinic. Ann Pharmacother 2002;36:769-774
48. van den Besselaar AMHP. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2001;12:35-40
49. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995;346:1085-1087
50. Gosselin R, Owings JT, White RH, et al. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 2000;83:698-703
51. Biasiolo A, Rampazzo P, Furnari O, Filippi B, Pengo V. Comparison between routine laboratory prothrombin time measurements and fingerstick determinations using a near-patient testing device (Pro-Time®). Thromb Res 2000;97:495-498
52. Fairweather RB, Ansell J, van den Besselaar AMHP, et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy. Laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med 1998;122:768-781
53. Mörsdorf S, Erdlenbruch W, Taborski U, et al. Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspects. Semin Thromb Hemost 1999;25:109-115
54. Poller L, Keown M, Chauhan N, et al. European Concerted Action on Anticoagulation. Use of plasma samples to derive international sensitivity index for whole-blood prothrombin time monitors. Clin Chem 2002;48:255-260